A living hemp plant contains almost no CBD. That sounds wrong, but it is true. What the plant actually builds is CBDA, cannabidiolic acid, and it only becomes the CBD everyone knows after heat knocks a small acid group off the molecule. That conversion is called decarboxylation, and it happens during smoking, vaping, baking, or any deliberate heating step. It also happens slowly, over months, as plant material ages at room temperature.
So CBDA is not some exotic new cannabinoid. It is the original. Every bottle of CBD oil started its life as CBDA in a field somewhere.
Raw versus activated
For a long time, CBDA was treated as nothing more than a precursor, the unfinished version you had to cook to get the good stuff. That thinking has shifted. CBDA turns out to behave differently in the body than CBD does, not just weaker or stronger but different, and a few of those differences are worth knowing.
The clearest one is absorption. Animal studies have found CBDA reaches the bloodstream far more readily than CBD when taken orally, in some studies several times higher for the same dose. CBD is famously hard for the body to absorb, with oral bioavailability estimated somewhere around 6 to 19 percent, so a related molecule that absorbs better caught researchers’ attention quickly.
What the research says so far
Two areas come up again and again in CBDA studies, and both come with the same caveat: this is mostly preclinical work in animals, not finished human trials.
The first is nausea. Rodent research, much of it from Linda Parker’s lab in Canada working with Raphael Mechoulam, found CBDA reduced nausea behaviors at doses far lower than CBD needed, apparently by acting on serotonin receptors. In some of those studies CBDA worked at one thousandth the CBD dose, which is a striking number even for rat research.
The second is inflammation. CBDA’s structure resembles the shape that lets NSAIDs like ibuprofen work, and lab studies show it inhibits the COX-2 enzyme, one of the same enzymes those drugs target. Whether that translates into meaningful anti-inflammatory effects in a person taking a raw hemp product is not established. Lab dishes are not people.
You may also remember CBDA from a widely shared 2022 Oregon State study that found it, along with CBGA, blocked a step in how the COVID virus entered cells. That was lab-dish work too, and no, it did not mean hemp prevents COVID, whatever the headlines implied that week.
Where you actually find CBDA
Because heat destroys it, CBDA lives in products that skip the oven:
- Raw hemp juice or smoothies made from fresh plant material
- Raw or “full plant” tinctures labeled as containing CBDA
- Capsules made from unheated hemp extract
- Some full-spectrum oils, in small amounts, when processing stayed gentle
Check the lab report if you want to know what you are getting. A certificate of analysis lists CBDA and CBD separately, and the ratio tells you how much heat the extract saw. A product marketed as raw with almost no CBDA on its panel is telling on itself.
Should you care?
Honest answer: it depends on your patience for early science. The absorption data is real, the nausea research in animals is consistent and interesting, and human trials are only now starting to catch up. If you already use CBD and it works for you, there is no urgent reason to switch. If oral CBD never seemed to do much, a raw product with CBDA is a reasonable thing to experiment with, taken with the same care as anything else: start with a small dose, keep it consistent for a couple weeks, and talk with your doctor first if you take prescription medications, since cannabinoids can affect how the liver processes some drugs.
And store raw products in the fridge. The whole point of CBDA is that it has not met heat yet. Your countertop in an Alabama summer will finish the decarboxylation for you whether you wanted it or not.